MOR - JMP cuts Incyte to market perform cites need for acquisition
2024-02-14 15:20:31 ET
More on Incyte
- Incyte Corporation (INCY) Q4 2023 Earnings Call Transcript
- Incyte Corporation 2023 Q4 - Results - Earnings Call Presentation
- Incyte: Overly Reliant On Jakafi Despite Positive Phase 2 Results For Axatilimab
- Incyte Q4 2023 Earnings Preview
- Incyte buys global rights for tafasitamab from MorphoSys